Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FELT: Lercanidipine and Enalapril in Essential Hypertension
NCT01093807Phase 2Completed
- Sponsor
- Recordati SpA
- Start
- Mar 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lercanidipine, enalapril in essential hypertension, sponsored by Recordati SpA. Started Mar 2010; status: completed.
02
Drugs
lercanidipineenalapril
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01093807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01093807.